Xiao Li

机构：Zhengzhou University of Science and Technology · ORCID：0000-0003-4135-2275

发表论文 43 篇 · 总被引 686 次 · h-index 11

代表论文

• Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer (2020 · Aging · 被引 44)
• Diabetes mellitus induced by immune checkpoint inhibitors (2020 · Diabetes/Metabolism Research and Reviews · 被引 31)
• High expression of PTGES3 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma (2022 · International Immunopharmacology · 被引 28)
• GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing (2024 · Advanced Science · 被引 24)
• Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma (2022 · Frontiers in Immunology · 被引 17)
• The lymphocyte-to-monocyte ratio could predict the efficacy of PD-1 inhibitors in patients with advanced cancer (2020 · Translational Cancer Research · 被引 15)